Source: Annual Congress 2006 - Recent advances in the treatment of COPD and acute lung injury
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
S. Boero, M. Silvestri, F. Sabatini, A. Nachira, G. A. Rossi (Genoa, Italy). Inhibition of human lung fibroblast functions by roflumilast N-oxide. Eur Respir J 2006; 28: Suppl. 50, 3845

Member's Comments

No comment yet.

Related content which might interest you: Roflumilast N-oxide reduces human fibroblast function Source: Annual Congress 2007 - Miscellaneous pulmonary pharmacology Year: 2007 Roflumilast N-oxide, a PDE4 inhibitor, curbs bleomycin-induced lung fibroblast activation in vitro Source: Annual Congress 2011 - Airway smooth muscle cells and fibroblasts: cell biology Year: 2011 The PDE4 inhibitor roflumilast N-oxide partly reversed TGFß1-induced changes in collagen I and E-cadherin expression in human airway epithelial cells Source: Annual Congress 2008 - Novel experimental approaches to understanding asthma and COPD Year: 2008 Inhibition of LPS-induced cytokine/chemokine production from human lung macrophages by roflumilast is enabled by autocrine PGE2 Source: Annual Congress 2010 - Macrophages: cell biology and disease-specific characteristics Year: 2010 Effects of aclidinium on human lung fibroblast activation in vitro Source: Annual Congress 2011 - Understanding disease and drug mechanisms Year: 2011 Proteoglycan production in cultured human lung fibroblasts is synergistcally inhibited by combination of budesonide and formoterol Source: Eur Respir J 2003; 22: Suppl. 45, 286s Year: 2003 COX inhibition enhances remodelling processes in human lung fibroblasts Source: Annual Congress 2010 - Regulation of airway pharmacology Year: 2010 Effect of roflumilast N-oxide on non-typable haemophilus influenzae (NTHi) interaction with human airway epithelial A549 cells Source: Annual Congress 2011 - Epithelial cell biology Year: 2011 Anti-inflammatory effects of roflumilast N-oxide and dexamethasone in human bronchial epithelial cells stimulated with toll-like receptor agonists Source: Annual Congress 2013 –The pulmonary epithelium: recent developments Year: 2013 Protective effect of MAPK inhibitors and budesonide against apoptosis induced by TGF-β in primary cultures of human bronchial epithelial cells Source: Eur Respir J 2003; 22: Suppl. 45, 394s Year: 2003 LATE-BREAKING ABSTRACT: Roflumilast and its active metabolite inhibit LPS-induced cytokines production from human parenchymal and bronchial explants: interaction with formoterol Source: Annual Congress 2009 - Airway cell biology Year: 2009 Modulation of TNFα-induced ICAM-1 expression in a human bronchial epithelial cell line (Beas-2B) by roflumilast N-oxide (RNO), salmeterol (Sal) and budesonide (Bud) Source: Annual Congress 2007 - Miscellaneous pulmonary pharmacology II Year: 2007 The PDE4 inhibitor roflumilast N-oxide partly restored cigarette smoke (CS)-induced tight junction disassembly in human airway epithelial cells (Calu-3) – role of MAPK Source: Annual Congress 2008 - Basic science in asthma and COPD II Year: 2008 Statins inhibit human lung fibroblast production and activation of MMPs Source: Eur Respir J 2007; 30: Suppl. 51, 692s Year: 2007 Cytokine-induced production of eotaxin-3 by human lung epithelial cells is inhibited by levocetirizine Source: Eur Respir J 2005; 26: Suppl. 49, 98s Year: 2005 HDAC2-independent anti-inflammatory effects of budesonide in human lung fibroblasts Source: Annual Congress 2011 - Recent developments in COPD Year: 2011 Rapid inhibitory effects of budesonide and formoterol on bradykinin-induced Ca2+ mobilization in human lung fibroblasts Source: Annual Congress 2010 - Regulation of airway pharmacology Year: 2010 Roflumilast N-oxide (RNO) alleviates from RSV-induced loss of ciliated cells and enhanced MUC5AC in differentiated human bronchial epithelial cells (D-HBE) Source: Annual Congress 2010 - Regulation of airway pharmacology Year: 2010 TGFβ-induced proteoglycan production and α-smooth muscle actin expression in cultured human lung fibroblasts is inhibited by combination of budesonide and formoterol Source: Eur Respir J 2004; 24: Suppl. 48, 251s Year: 2004 Dexamethasone and formoterol modulate human rhinovirus induced MMP-9 expression Source: Annual Congress 2010 - Lung cell biology and immunology Year: 2010